Ginkgo

XWELL, Inc. Reports Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 14, 2023
Dubai International Airport, Acquisition, NYSE, DNA, TGS, Bank statement, Collection, CXM, Digital, COVID-19 testing, JFK, Massage, FASB, Health, COVID-19, Airport, GAAP, Relaxation, Wellness, Partnership, CDC, Genomics, Growth, Hydro massage, SARS-CoV-2, Ginkgo, The Company, Traveler, Face, Public, Abu Dhabi International Airport, Hair removal, Video game, Risk management, Airline, Vaccine, Beauty salon, Pharmaceutical industry, Amsterdam Airport Schiphol, Boston

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter ended September 30, 2023.

Key Points: 
  • Third quarter 2023 results included non-cash goodwill and intangible asset impairment charges totaling approximately $6.8 million.
  • Demonstrating the effect of the Company’s cost-savings initiatives, third quarter 2023 total cost of sales decreased 43% from the same quarter in 2022 and third quarter 2023 general and administrative expenses decreased 35% from the third quarter of 2022.
  • Additionally, at the beginning of the third quarter of 2023, the Company began reporting operating results for HyperPointe within its XpresCheck business.
  • Third quarter 2023 results included non-cash impairment charges totaling approximately $6.8 million.

Arbor Biotechnologies Announces Collaboration with Ginkgo Bioworks to Advance the Discovery and Development of Precision Gene Editors

Retrieved on: 
Tuesday, December 12, 2023
NYSE, DNA, Gene editing, Protein engineering, Genome, Ginkgo Bioworks, CRISPR, PAMS, Ginkgo, Patient, Codebase, Foundry, Vaccine, Pharmaceutical industry, Arbor

Arbor utilizes its computational metagenomic discovery engine and protein engineering expertise to identify and optimize genetic editors with the potential to treat a broad range of genetic diseases.

Key Points: 
  • Arbor utilizes its computational metagenomic discovery engine and protein engineering expertise to identify and optimize genetic editors with the potential to treat a broad range of genetic diseases.
  • "Ginkgo's expertise aligns well with our goals, and their technology will synergize with our in-house capabilities, potentially fueling a faster, more efficient expansion of our toolbox of gene editing technologies."
  • "This collaboration with Arbor is an exciting project for us, as it gives us an opportunity to leverage our platform-driven approach to contribute to the gene editing sector's fast-moving evolution.
  • We look forward to expanding our capabilities in this field by working with such an innovative pioneer as Arbor to power technologies with the potential for transformative impact."

Agrivalle and Ginkgo Bioworks Enter Multiyear Strategic Partnership to Accelerate Next-Gen Ag Biological Products

Retrieved on: 
Friday, December 8, 2023
Agriculture, Ginkgo, NYSE, DNA, Partnership, Dietary supplement

Together, the companies will collaborate on building cutting edge technologies to advance Agrivalle's biological products, including next-gen fertilizers and biocontrol agents.

Key Points: 
  • Together, the companies will collaborate on building cutting edge technologies to advance Agrivalle's biological products, including next-gen fertilizers and biocontrol agents.
  • Ginkgo is bringing its suite of advanced biology tools to the partnership with Agrivalle.
  • "We are so excited to partner with Agrivalle on getting groundbreaking biological products into the hands of growers," said Jason Kelly, co-founder and CEO of Ginkgo Bioworks.
  • "Choosing Ginkgo as a strategic partner will enable Agrivalle products to be at the forefront of agricultural excellence," said André Kraide, CEO of Agrivalle.

Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan

Retrieved on: 
Wednesday, December 6, 2023
Kobe University, NYSE, DNA, Gene, Marketing, Synthetic biology, Postgraduate education, AAV, MOU, Vaccine, Ginkgo

Together, Synplogen and Ginkgo intend to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan.

Key Points: 
  • Together, Synplogen and Ginkgo intend to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan.
  • Ginkgo and Synplogen will explore global business collaboration opportunities for DNA manufacturing.
  • Synplogen's OGAB™ DNA synthesis services have the ability to synthesize DNA of various lengths up to 100 kbp.
  • Furthermore, Ginkgo and Synplogen will work to extend the reach of Ginkgo's gene therapy services in Japan.

Vivici Selects Ginkgo Bioworks to Extend Their Range of Novel Dairy Proteins

Retrieved on: 
Monday, November 27, 2023
NYSE, DNA, Senior, Protein, Fermentation, DSM, Ginkgo Bioworks, Partnership, Commercialization, Food preservation, Vaccine, Ginkgo

Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation.

Key Points: 
  • Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation.
  • Ginkgo will use its Protein Production Services and generative AI platform to deliver best-in-class candidate strains to Vivici.
  • Vivici will use the strains from this collaboration to extend their existing range of proteins, supporting innovative specialised nutrition companies, to bring planet-friendly nutrition to consumers.
  • Recognizing the need for alternatives to traditional animal agriculture, Vivici employs precision fermentation techniques to produce animal-free dairy proteins with microorganisms.

Vivici Selects Ginkgo Bioworks to Extend Their Range of Novel Dairy Proteins

Retrieved on: 
Monday, November 27, 2023
NYSE, DNA, Senior, Protein, Fermentation, DSM, Ginkgo Bioworks, Partnership, Commercialization, Food preservation, Vaccine, Ginkgo

Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation.

Key Points: 
  • Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation.
  • Ginkgo will use its Protein Production Services and generative AI platform to deliver best-in-class candidate strains to Vivici.
  • Vivici will use the strains from this collaboration to extend their existing range of proteins, supporting innovative specialised nutrition companies, to bring planet-friendly nutrition to consumers.
  • Recognizing the need for alternatives to traditional animal agriculture, Vivici employs precision fermentation techniques to produce animal-free dairy proteins with microorganisms.

Foremost Farms Selects Ginkgo Bioworks to Develop Technology for Upcycling Dairy Co-products

Retrieved on: 
Thursday, November 9, 2023
Cell engineering, NYSE, Biotechnology, Farm, Cheese, Metabolic engineering, Carbon, Ginkgo, Carbon footprint, Environment, Biology, Foremost, Commercial, Partnership, Farmer, Butter, D, DNA, Dairy, Agriculture

Through this partnership, Foremost Farms will leverage Ginkgo's bioproduction services to develop and commercialize a new technology that could help upcycle billions of pounds of dairy co-products each year.

Key Points: 
  • Through this partnership, Foremost Farms will leverage Ginkgo's bioproduction services to develop and commercialize a new technology that could help upcycle billions of pounds of dairy co-products each year.
  • Foremost Farms has selected Ginkgo as its partner of choice to develop a new upcycling technology because of Ginkgo's leading metabolic engineering and analytical capabilities, which will allow strain optimization for challenging environmental conditions while avoiding common toxicity issues.
  • Ginkgo aims to help Foremost build a technology to reduce this carbon footprint by upcycling these low-value co-products.
  • "We're excited to partner with Ginkgo Bioworks, which can uniquely help Foremost Farms realize its goals.

Bison Ventures Debuts $135M Fund to Invest in Frontier Technology Companies Addressing the World’s Biggest Challenges

Retrieved on: 
Tuesday, November 7, 2023
Finance, Professional Services, Other Technology, Technology, Asset Management, Bison, Climate, Ginkgo, Engineering, Disease, Woman, Bill & Melinda Gates Foundation, Investment, Synthetic biology, Semiconductor, Robotics, Climate change, Cryptocurrency, Pharmaceutical industry

Today Bison Ventures , a venture capital firm that invests in early-stage frontier technology companies, announced the close of its debut $135M fund.

Key Points: 
  • Today Bison Ventures , a venture capital firm that invests in early-stage frontier technology companies, announced the close of its debut $135M fund.
  • The firm is dedicated to investing in and supporting teams using innovative science and deep technology to address some of the world’s most pressing challenges.
  • From solutions that address climate change to treating disease to meeting the world’s insatiable demand for compute, Bison backs bold, technical solutions that have potential for massive scale.
  • Notably, over 80% of the CEOs backed by Bison to date are part of groups traditionally under-represented in venture-backed companies, including half who are women.

ZOA Energy Launches Revolutionary Five-in-One Pre-Workout Supplement with Setria® Glutathione

Retrieved on: 
Tuesday, November 7, 2023
Research, Dwyane Wade, Sport, Food, Creatine, RD, Certification, Dwayne Johnson, MBA, Nitric oxide, Athlete, Interview, Β-Alanine, Trust, Rock, Disease, Tyrosine, Glutathione, NO, Alanine, Ginkgo, Safety, Citrulline, Electrolyte, Food and Drug Administration, Fatigue, Dietary supplement, ZOA, Amazon

NEW YORK, Nov. 7, 2023 /PRNewswire-PRWeb/ -- The newly launched ZOA+ Powder pre-workout supplement has discerning athletes running to hit the gym to maximize their workouts. ZOA+ includes premium ingredients like Setria®, a clinically studied and patented form of glutathione that helps to replenish the body's reserves*, in its five-in-one advanced formula with a powerful combination of Nitric Oxide (NO) alongside training support, natural caffeine, and electrolytes, while promoting focus for a peak performance workout.

Key Points: 
  • ZOA+ Powder is a natural addition to the growing list of products containing Kyowa Hakko's Setria® Glutathione.
  • Research suggests that Setria® Glutathione may support an increase in NO production when combined with L-Citrulline**, which is also contained in ZOA+.
  • Formulated by ZOA Energy Co-founder and Chief Innovation Officer, Dave Rienzi, ZOA+ Powder promises a superior fitness experience.
  • According to Rienzi, "This launch represents a remarkable stride for ZOA Energy, as we reshape the standards of excellence in the fitness industry and beyond."

Ginkgo Bioworks Announces Date of Third Quarter 2023 Results Presentation

Retrieved on: 
Wednesday, November 1, 2023
Q&A, Ginkgo, NYSE, DNA, Online shopping

BOSTON, Nov. 1, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2023, on Wednesday, November 8, 2023, beginning at 5:30 p.m. ET.

Key Points: 
  • Presentation and Q&A session scheduled for post-market on Wednesday, November 8, 2023
    BOSTON, Nov. 1, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2023, on Wednesday, November 8, 2023, beginning at 5:30 p.m.
  • ET.
  • The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
  • To ask a question ahead of the presentation, please submit them to @ Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected] .